vs
太平洋生物科学（ASMB）与SWK Holdings Corp（SWKH）财务数据对比。点击上方公司名可切换其他公司
太平洋生物科学的季度营收约是SWK Holdings Corp的1.2倍（$10.8M vs $8.7M），太平洋生物科学同比增速更快（57.6% vs -29.7%），SWK Holdings Corp自由现金流更多（$26.8M vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
SWK Holdings Corp是一家专注于医疗健康与生命科学领域的专业金融企业，为生物技术、制药、医疗器械及诊断类企业提供特许权使用费货币化、结构性债务、资产支持贷款等定制化融资服务，核心市场以北美地区为主。
ASMB vs SWKH — 直观对比
营收规模更大
ASMB
是对方的1.2倍
$8.7M
营收增速更快
ASMB
高出87.3%
-29.7%
自由现金流更多
SWKH
多$41.9M
$-15.2M
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $8.7M |
| 净利润 | $-9.2M | $-19.4M |
| 毛利率 | — | — |
| 营业利润率 | -100.9% | 9.9% |
| 净利率 | -85.2% | — |
| 营收同比 | 57.6% | -29.7% |
| 净利润同比 | 4.3% | -430.2% |
| 每股收益（稀释后） | $-0.72 | $-1.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBSWKH
| Q4 25 | — | $8.7M | ||
| Q3 25 | $10.8M | $10.9M | ||
| Q2 25 | $9.6M | $10.1M | ||
| Q1 25 | $9.4M | $11.8M | ||
| Q4 24 | $7.4M | $12.4M | ||
| Q3 24 | $6.8M | $10.4M | ||
| Q2 24 | $8.5M | $10.8M | ||
| Q1 24 | $5.8M | $11.4M |
净利润ASMBSWKH
| Q4 25 | — | $-19.4M | ||
| Q3 25 | $-9.2M | $8.8M | ||
| Q2 25 | $-10.2M | $3.5M | ||
| Q1 25 | $-8.8M | $4.5M | ||
| Q4 24 | — | $5.9M | ||
| Q3 24 | $-9.6M | $3.5M | ||
| Q2 24 | $-11.2M | $3.7M | ||
| Q1 24 | $-9.1M | $468.0K |
营业利润率ASMBSWKH
| Q4 25 | — | 9.9% | ||
| Q3 25 | -100.9% | 61.3% | ||
| Q2 25 | -115.2% | 46.1% | ||
| Q1 25 | -105.5% | 68.6% | ||
| Q4 24 | — | 44.7% | ||
| Q3 24 | -160.1% | 39.2% | ||
| Q2 24 | -143.0% | 8.3% | ||
| Q1 24 | -185.5% | 9.5% |
净利率ASMBSWKH
| Q4 25 | — | — | ||
| Q3 25 | -85.2% | 80.7% | ||
| Q2 25 | -105.9% | 35.2% | ||
| Q1 25 | -93.6% | 38.4% | ||
| Q4 24 | — | 47.5% | ||
| Q3 24 | -140.4% | 33.3% | ||
| Q2 24 | -130.7% | 33.9% | ||
| Q1 24 | -156.9% | 4.1% |
每股收益（稀释后）ASMBSWKH
| Q4 25 | — | $-1.59 | ||
| Q3 25 | $-0.72 | $0.72 | ||
| Q2 25 | $-1.33 | $0.29 | ||
| Q1 25 | $-1.17 | $0.37 | ||
| Q4 24 | — | $0.47 | ||
| Q3 24 | $-1.51 | $0.28 | ||
| Q2 24 | $-1.98 | $0.30 | ||
| Q1 24 | $-1.66 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $42.8M |
| 总债务越低越好 | — | $33.0M |
| 股东权益账面价值 | $182.7M | $235.1M |
| 总资产 | $240.0M | $272.4M |
| 负债/权益比越低杠杆越低 | — | 0.14× |
8季度趋势，按日历期对齐
现金及短期投资ASMBSWKH
| Q4 25 | — | $42.8M | ||
| Q3 25 | $22.5M | $10.2M | ||
| Q2 25 | $24.0M | $8.0M | ||
| Q1 25 | $23.4M | $29.8M | ||
| Q4 24 | $38.3M | $5.9M | ||
| Q3 24 | $28.5M | $17.2M | ||
| Q2 24 | $19.2M | $5.5M | ||
| Q1 24 | $18.7M | $5.5M |
总债务ASMBSWKH
| Q4 25 | — | $33.0M | ||
| Q3 25 | — | $33.0M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $33.0M | ||
| Q4 24 | — | $33.0M | ||
| Q3 24 | — | $33.0M | ||
| Q2 24 | — | $33.0M | ||
| Q1 24 | — | $33.0M |
股东权益ASMBSWKH
| Q4 25 | — | $235.1M | ||
| Q3 25 | $182.7M | $254.2M | ||
| Q2 25 | $18.1M | $246.5M | ||
| Q1 25 | $27.1M | $292.7M | ||
| Q4 24 | $33.4M | $288.7M | ||
| Q3 24 | $26.0M | $283.4M | ||
| Q2 24 | $34.7M | $282.8M | ||
| Q1 24 | $32.6M | $279.9M |
总资产ASMBSWKH
| Q4 25 | — | $272.4M | ||
| Q3 25 | $240.0M | $289.4M | ||
| Q2 25 | $80.8M | $285.7M | ||
| Q1 25 | $99.0M | $331.3M | ||
| Q4 24 | $119.2M | $332.2M | ||
| Q3 24 | $100.3M | $321.3M | ||
| Q2 24 | $115.3M | $321.0M | ||
| Q1 24 | $119.9M | $322.0M |
负债/权益比ASMBSWKH
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $27.3M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $26.8M |
| 自由现金流率自由现金流/营收 | -140.7% | 308.1% |
| 资本支出强度资本支出/营收 | 0.4% | 5.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $43.2M |
8季度趋势，按日历期对齐
经营现金流ASMBSWKH
| Q4 25 | — | $27.3M | ||
| Q3 25 | $-15.1M | $906.0K | ||
| Q2 25 | $-16.8M | $7.8M | ||
| Q1 25 | $-23.4M | $8.3M | ||
| Q4 24 | $-51.1M | $23.0M | ||
| Q3 24 | $-15.2M | $6.3M | ||
| Q2 24 | $-17.1M | $5.4M | ||
| Q1 24 | $-18.4M | $4.4M |
自由现金流ASMBSWKH
| Q4 25 | — | $26.8M | ||
| Q3 25 | $-15.2M | $557.0K | ||
| Q2 25 | — | $7.7M | ||
| Q1 25 | — | $8.2M | ||
| Q4 24 | $-51.1M | $22.9M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | $-17.1M | $5.4M | ||
| Q1 24 | $-18.4M | — |
自由现金流率ASMBSWKH
| Q4 25 | — | 308.1% | ||
| Q3 25 | -140.7% | 5.1% | ||
| Q2 25 | — | 77.0% | ||
| Q1 25 | — | 69.1% | ||
| Q4 24 | -695.2% | 185.3% | ||
| Q3 24 | — | 60.4% | ||
| Q2 24 | -200.6% | 49.7% | ||
| Q1 24 | -317.7% | — |
资本支出强度ASMBSWKH
| Q4 25 | — | 5.9% | ||
| Q3 25 | 0.4% | 3.2% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.0% | 0.8% | ||
| Q4 24 | 0.4% | 1.1% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.2% | 0.2% | ||
| Q1 24 | 0.2% | 0.0% |
现金转化率ASMBSWKH
| Q4 25 | — | — | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 3.93× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | 1.47× | ||
| Q1 24 | — | 9.47× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASMB
暂无分部数据
SWKH
| Finance Receivables Segment | $8.4M | 96% |
| Other | $329.0K | 4% |
